未登录 分享 收藏
分享 收藏
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer: A Multicenter Phase Ib Trial (RECAP)-SAKK 41/16 Bastian, Sara; Joerger, Markus; Holer, Lisa; Baertschi, Daniela; Guckenberger, Matthias; Jochum, Wolfram; Koeberle, Dieter; Siebenhuner, Alexander R.; Wicki, Andreas; Berger, Martin D.; Winterhalder, Ralph C.; Largiader, Carlo R.; Loffler, Melanie; Mosna-Firlejczyk, Katarzyna; Maranta, Angela Fischer; Pestalozzi, Bernhard C.; Csajka, Chantal; von Moos, Roger 分享 收藏
Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer (vol 19, e0301271, 2024) 奥拉帕利作为铂敏感、BRCA1/2胚系突变型转移性胰腺癌的维持治疗，不具有成本效益（卷19，e0301271，2024） Mehra, Tarun; Lupatsch, Judith E.; Koessler, Thibaud; Dedes, Konstantin; Siebenhuener, Alexander Reinhard; von Moos, Roger; Schwenkglenks, Matthias E. 分享 收藏
Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study Jolidon, Vladimir; Eicher, Manuela; Peytremann-Bridevaux, Isabelle; Aebi, Stefan; Anchisi, Sandro; Bettini, Adrienne; Chalandon, Yves; Dietrich, Pierre-Yves; Duchosal, Michel A.; Durr, Donat; Peters, Solange; von Moos, Roger; Wicki, Andreas; Arditi, Chantal 分享 收藏
Final Overall Survival (OS) analysis of the SAKK 21/12 trial. CR1447 in HR+/HER2-metastatic breast cancer and androgen receptor positive triple negative breast cancer Vetter, Marcus; Lisa, Holer; Rothgiesser, Karin; Schonfeld, Wolfgang; Riniker, Salome; von Moos, Roger; Torjan, Andreas; Kralidis, Elena; Rabaglio, Manuela; Fehr, Mathias K.; Mueller, Andreas; Thurlimann, Beat 分享 收藏
First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17 Mark, Michael; Froesch, Patrizia; Gysel, Katrin; Rothschild, Sacha I.; Addeo, Alfredo; Ackermann, Christoph J.; Chiquet, Sabrina; Schneider, Martina; Ribi, Karin; Maranta, Angela Fischer; Bastian, Sara; von Moos, Roger; Joerger, Markus; Frueh, Martin 分享 收藏
Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma de Joode, Karlijn; Mora, Alfonso Rojas; van Schaik, Ron H. N.; Zippelius, Alfred; van der Veldt, Astrid; Gerard, Camille Lea; Laeubli, Heinz; Michielin, Olivier; von Moos, Roger; Joerger, Markus; Levesque, Mitchell P.; Aeppli, Stefanie; Mangana, Johanna; Mangas, Cristina; Trost, Nadine; Meyer, Stefan; Parvex, Sandra Leoni; Mathijssen, Ron; Metaxas, Yannis 分享 收藏
Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study Piringer, Gudrun; Thaler, Josef; Anchisi, Sandro; Geffriaud-Ricouard, Christine; Gueldner, Max; Scholten, Felicitas; Derigs, Hans-Guenter; Bohanes, Pierre; Gruenberger, Birgit; Schwarz, Leonora; von Moos, Roger; Hofheinz, Ralf-Dieter 分享 收藏
Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy Tannock, I. F.; Bouche, G.; Goldstein, D. A.; Goto, Y.; Lichter, A. S.; Prabhash, K.; Ranganathan, P.; Saltz, L. B.; Sonke, G. S.; Strohbehn, G. W.; von Moos, R.; Ratain, M. J. 分享 收藏
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer Mamot, Christoph; Wicki, Andreas; Hasler-Strub, Ursula; Riniker, Salome; Li, Qiyu; Holer, Lisa; Bartschi, Daniela; Zaman, Khalil; von Moos, Roger; Dedes, Konstantin J.; Boos, Laura A.; Novak, Urban; Bodmer, Alexandre; Ritschard, Reto; Obermann, Ellen C.; Tzankov, Alexandar; Ackermann, Christoph; Membrez-Antonioli, Veronique; Zurrer-Hardi, Ursina; Caspar, Clemens B.; Deuster, Stefanie; Senn, Martin; Winterhalder, Ralph; Rochlitz, Christoph 分享 收藏
Safety analysis after 11 years of follow-up of the randomized phase III trial SAKK22/99: upfront chemotherapy in advanced HER2 positive breast cancer Rabaglio, Manuela; Dietrich, Daniel; Scheibe, Bernhard; Ruhstaller, Thomas; Nole, Franco; Eppenberger, Serenella; Oehlschlegel, Christian; Hess, Dagmar; Mamot, Christoph; Munzone, Elisabetta; Pestalozzi, Bernhard; Aebi, Stefan; Vetter, Marcus; Thuerlimann, Beat; von Moos, Roger; Zaman, Khalil; Pagani, Olivia 分享 收藏
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study Joerger, Markus; Hundsberger, Thomas; Haefliger, Simon; von Moos, Roger; Hottinger, Andreas F.; Kaindl, Thomas; Engelhardt, Marc; Marszewska, Michalina; Lane, Heidi; Roth, Patrick; Stathis, Anastasios 分享 收藏
Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14] Hasler-Strub, Ursula; Mueller, Andreas; Li, Qiyu; Thuerlimann, Beat; Ribi, Karin; Gerber, Stefan; von Moos, Roger; Fehr, Mathias; Rochlitz, Christoph; Zaman, Khalil; Aebi, Stefan; Hochstrasser, Andreas; Gick, Ute; Baertschi, Daniela; Greuter, Stefan; Schreiber, Alexander; Caspar, Clemens B.; Trojan, Andreas; Condorelli, Rosaria; Ruhstaller, Thomas 分享 收藏
Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP) Schmulenson, Eduard; Bovet, Cedric; Theurillat, Regula; Decosterd, Laurent Arthur; Largiader, Carlo R.; Prost, Jean-Christophe; Csajka, Chantal; Baertschi, Daniela; Guckenberger, Matthias; von Moos, Roger; Bastian, Sara; Joerger, Markus; Jaehde, Ulrich 分享 收藏
Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study Mark, M.; Rusakiewicz, S.; Fruh, M.; Hayoz, S.; Grosso, F.; Pless, M.; Zucali, P.; Ceresoli, G. L.; Maconi, A.; Schneider, M.; Froesch, P.; Tarussio, D.; Benedetti, F.; Dagher, J.; Kandalaft, L.; Von Moos, R.; Tissot-Renaud, S.; Schmid, S.; Metaxas, Y. 分享 收藏
分享 收藏
分享 收藏
Impact of age on the activity of aflibercept plus FOLFIRI in metastatic colorectal cancer (mCRC): Real world data from the QoLiTrap study Thaler, J.; Kroning, H.; Zahn, M-O.; Scholten, F.; Derigs, H-G.; Pederiva, S.; Anchisi, S.; Bohanes, P.; Grunberger, B.; Windemuth-Kieselbach, C.; Piringer, G.; Von Moos, R.; Hofheinz, R-D. 分享 收藏
Anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple-negative, EGFR positive breast cancer: A multicenter single arm phase II trial [SAKK 24/14] Wicki, A.; Mamot, C.; Hasler-Strub, U.; Riniker, S.; Li, Q.; Holer, L.; Baertschi, D.; Zaman, K.; Von Moos, R.; Dedes, K. J.; Novak, U.; Bodmer, A.; Ritschard, R.; Obermann, E.; Ackermann, C. J.; Membrez-Antonioli, V.; Zuerrer, U.; Caspar, C. B.; Rochlitz, C.; Winterhalder, R. C. 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
